The following Structured Product Label (SPL) was submitted to the FDA by Budpak Inc. for the product Triple Antibiotic (NDC 27293-014). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding otc - active ingredient, otc - purpose, indications & usage, warnings, otc - do not use, otc - ask doctor, otc - stop use, otc - keep out of reach of children, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Otc - Active Ingredient
Active IngredientsBacitracin Zinc
400UNeomycin 3.5mg
Polymyxin B sulfate 5000U
Otc - Purpose
PurposeFirst Aid AntibioticFirst Aid AntibioticFirst Aid Antibiotic
Indications & Usage
Uses first
aid to help prevent infection in •minor
cuts •scrapes •burns
Warnings
WarningsFor external use only
Otc - Do Not Use
Do not use •in the eyes •if
you are allergic to any of the ingredients
•longer than 1 week unless
directed by a doctor •over large areas of the body
Otc - Ask Doctor
Ask a doctor before use on •on deep
puncture wounds, animal bites, or serious burns
Otc - Stop Use
Stop use and consult a doctor if the
condition persists or gets worse, or if a rash or other allergic reaction
develops
Otc - Keep Out Of Reach Of Children
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
Dosage & Administration
Directions
•Clean the
affected area and dry thoroughly•Apply a small
amount of this product (an amount equal to the surface area of the tip of a finger)
on the area 1 to 3 times daily•May be covered
with a sterile bandage
Other
Other information•Store at 68
to 77F (20C-25C) •See carton or
tube crimp for lot number and expiration date
Inactive Ingredient
Inactive ingredients Petrolatum,
Mineral oil, Ozocerite, Propanediol, Methylparaben, Propylparaben
Package Label.Principal Display Panel
Package Label
* Please review the disclaimer below.